Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21. | Cancer Lett | 2024 | 38387756 | PubTator, text mining | PubMed |
| Bivalent chromatin: a developmental balancing act tipped in cancer. | Biochem Soc Trans | 2024 | 38385532 | PubTator, text mining | PubMed |
| m6A-methylated KCTD21-AS1 regulates macrophage phagocytosis through CD47 and cell autophagy through TIPR. | Commun Biol | 2024 | 38383737 | PubTator, text mining | PubMed |
| METTL14 affects UVB-induced human dermal fibroblasts photoaging via miR-100-3p biogenesis in an m6A-dependent manner. | Aging Cell | 2024 | 38380598 | PubTator, text mining | PubMed |
| M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells. | Cancer Biol Ther | 2024 | 38372700 | PubTator, text mining | PubMed |
| The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability. | Cell Rep | 2024 | 38358891 | PubTator, text mining | PubMed |
| IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD. | Cell Death Dis | 2024 | 38355626 | PubTator, text mining | PubMed |
| Exposure to bisphenol A affects transcriptome-wide N6-methyladenine methylation in ovarian granulosa cells. | Ecotoxicol Environ Saf | 2024 | 38354435 | PubTator, text mining | PubMed |
| Neonatal brain injury unravels transcriptional and signaling changes underlying the reactivation of cortical progenitors. | Cell Rep | 2024 | 38349790 | PubTator, text mining | PubMed |
| Transcriptome-wide profiling identifies colon cancer-associated m6A transcripts and potential RNA methyl modifiers. | Mol Biol Rep | 2024 | 38345740 | PubTator, text mining | PubMed |
| Nicotine-derived NNK promotes CRC progression through activating TMUB1/AKT pathway in METTL14/YTHDF2-mediated m6A manner. | J Hazard Mater | 2024 | 38341886 | PubTator, text mining | PubMed |
| HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38331110 | PubTator, text mining | PubMed |
| METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2. | J Clin Invest | 2024 | 38319733 | PubTator, text mining | PubMed |
| Human Umbilical Cord Mesenchymal Stem Cell Exosome-derived miR-335-5p Alleviated Lipopolysaccharide-induced Acute Lung Injury by Regulating the m6A Level of ITGβ4 Gene. | Curr Med Chem | 2024 | 38310394 | PubTator, text mining | PubMed |
| Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours. | Clin Transl Med | 2024 | 38303608 | PubTator, text mining | PubMed |
| METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation. | J Hematol Oncol | 2024 | 38302992 | PubTator, text mining | PubMed |
| Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets. | Cell Commun Signal | 2024 | 38302953 | PubTator, text mining | PubMed |
| Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies. | Sci Rep | 2024 | 38302672 | PubTator, text mining | PubMed |
| Alternative splicing and related RNA binding proteins in human health and disease. | Signal Transduct Target Ther | 2024 | 38302461 | PubTator, text mining | PubMed |
| Experimental prognostic model integrating N6-methyladenosine-related programmed cell death genes in colorectal cancer. | iScience | 2024 | 38299031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=28